Arax Advisory Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53K | Buy |
+170
| New | +$5.53K | ﹤0.01% | 2212 |
|
|
2025
Q1 | – | Sell |
-65
| Closed | -$5.32K | – | 2948 |
|
|
2024
Q4 | $5.32K | Buy |
65
+4
| +7% | +$327 | ﹤0.01% | 1720 |
|
|
2024
Q3 | $6.97K | Buy |
61
+9
| +17% | +$1.03K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $3.93K | Buy |
+52
| New | +$3.93K | ﹤0.01% | 1698 |
|